Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Todays RNS.

No getting away from it that things, albeit slowly, are looking up.

Can't believe that there is no activity whatsoever today, MM's holding deals back from release today perhaps!

Buys now going through at 10.75p, so looks like those who bought in the offer overpaid.

Not gloating as some no doubt will, usually of course those who never get things wrong and I admit to being tempted re the offer.

Today's RNS.

Two new none execs, both with plenty of experience in the areas Deltex are looking for and also with good connections in the field, this can only be good.

Not surprised though that this news is greeted with a falling sp, which goes to show that positive action on the contract front is the only thing that investors are bothered about.

Deleted as pointed out by a poster on a different site, my facts were wrong.

Apologies to those that may have been mislead.

Large Sell.

0811 hrs, sell of 500,000 went through at bottom price, I wonder how much the seller lost.

Would like to see at least something trickling through from the Physician payment increase in the USA that was announced on 16 June.

I appreciate that the announcement was less than a month ago, but the sp is only 2p above its all time low.

Yes, I know, patience is still required, but it ain't easy!

Large volume today, all sells and yet the sp finishes level.

Not like Deltex at all!!!!!!

Pre close update.

Excepts.
UK surgical probe sales 13% down due to NHS de-stocking; stronger sales since May.

Q I would like to know what those stronger sales since May are, IE 1%, 2% or what, far too vague.

NHS implementation drive re-launch expected in H2 2014

Q Will it work this time.

International surgical probes up 11% and Monitor sales up £150,000 (86%) on stronger export orders, (Hopefully mainly in the USA).

Great, although international probe sales are only up 11%, the 86% increase in Monitor sales will result in a far greater increase in probe sales in the next few months.

So looking good, although due to the general lack of interest in Deltex, I think this will have only a minimal effect on the SP.

So Monitor sales up 86% which although leading to a decent increase in probe sales, results in a level sp on opening and nil trades.

It looks like the market is in total apathy re Deltex due to similar apathy on the part of the company over the last few years.

Softly, Softly might catchy monkey, but it's not monkeys we are after, now is the time to push.

Now at its lowest price for the last 12 months and approaching the all time low.

They have to do something or at least update as to how things are progressing and the current situation.

It's my belief their problem as far as Investors / Market is concerned that they are effectively a 1-product company. It is expensive to employ sales teams and whether that's a discount via a third party or Direct makes little difference if you have only one product, it's a bit Go or, No-Go.
In the UK their effort is to the NHS who want to cut costs - even if they could be saving money in Healthcare overall. Such is the NHS. Yes I know there is Overseas income and maybe that will come good, -less any currency woes.

It's rather sad the sp has dipped so low . . . . any views on the Future?
Greekman: - you sure about your "patience?"

Hi Hangon,

Just got back from hol's so a bit out of touch, no idea as to Deltex future and I doubt if anyone has.

Results.

When I started to read the contents I thought looks good, what's not to like, then I reached the statement 'overall surgical probe sales down 3%' and it was the word overall that bothered me.

Then I got to the 'Circa 20 new enquiries from potential large accounts' and with
operating losses about the same I came to the conclusion that if and it's a big if, at least 50% of those enquiries result in contracts then Deltex will be over the, will they won't they make it line.
The problem as always with Deltex is what do they mean by large accounts and until we start to see actual figures from one or two of these accounts then I am still neither pro or con.

I am not going to comment on the contents of the evidence update RNS as no matter how good previous results have been, it tends not to result in notable contracts which is all that really matters.

Director/PDMR Shareholding


8 October 2014 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that on 7 October 2014 Mr Tim Irish, non-executive Director informed the Company of the purchase of 848,484 Ordinary Shares at a price of 8.25 pence per Ordinary Share through his Self Invested Personal Pension.

As a result Mr Irish's shareholding totals 1,348,484 ordinary shares (representing 0.63 per cent. of the issued share capital of Deltex Medical).

RNS,

2,200,000 shares bought, first time for a long while that an institution has bought into Deltex.

Do they know something we don't!

Another study shows how the CardioQ could save lives and time spent in hospital (must be almost 90 it total now)and yet again such a report has no effect on the sp which has been on a downward trend for so long now it's getting monotonous.

It only strengthens the fact that as there have been so many such reports that have no lasting effect on the sp, that contracts and only contracts will save this company.

If the CardioQ had been rubbished in a few or more medical studies then I could accept Deltex's position but as we all know that the CardioQ does work for both the benefits of the patients directly and indirectly by saving medical establishments money it makes me both angry at the lack of take up and the continuing sp decline.

Its difficult to feel positive about a product when it is so obvious that potential end users don't.

I do get fed up of posting negative posts (the RNS should be a pre-cursor to a positive post), but facts have to be faced.

We desperately need some news.

If the sp continues on it' downward direction, there soon won't be many investors to inform.

Speak to us now for gawds sake,

Month after month and still no sp mending news.

Is anyone at home or have they all locked up and gone home, just how much longer are we expected to believe?

Another company I am invested in changed it's CEO a week ago today, and this morning an RNS was released stating several things had been accelerated by quite a considerable time line.

The new CEO has a reputation for direct action and was bought in because of pressure by the big institutional investors.

Many investors in this company had commented for some time that things appeared to be going too slowly and that someone needed to get a grip and take a few more risks.

This brings me to Deltex
It makes me wonder again if Ewan Phillips is being too cautious and a too much Mr nice guy.

As said before, if the present action plan is not getting anywhere (we know things are progressing slowly) then surely it's time to look at a plan B.

Appreciate that I am probably talking to myself, but From a RNS last April,


The NHSE standard contract technical guidance for 2014/15 mandates that, by March 2015, all hospitals should "demonstrate to commissioners that trajectories for the intra-operative fluid management (IOFM) technologies are in place which are consistent with National Technology Adoption Centre (NTAC - now the Health Technology Adoption Programme) guidance".1,2.

It goes on to say that the guide for implementation of IOFM was published in 2013.

With just over 2 months to go I have seen very little progress regarding the above. I wonder just what action will be taken by the NHSE standard commissioners if insufficient evidence of take up is shown, they will probably just keep taking their no doubt hefty salaries and do nothing .

Whilst accepting that the main markets are the USA and a few other countries and that the NHS is almost a none starter (OK they have started, but appear to have stopped), is anyone else becoming despondent on these other markets as nothing appears to be moving.

I remember several posters including myself stating in 2012 that that year was make or break for Deltex, same was said in 2013 and again this year, so as we head for yet another year end passing with little progress, I wonder what 2015 will bring, more of the same, a takeover or will things start to finally pay off for all our patience.

Personally I have no idea which option is the most likely although on past form I feel that more of the same is probable.

It must be 2 years or so since I sold my holding greekman, I missed the rise to around 30p but I'm glad I exited. One day your faith in DEMG may hopefully bring you some reward, good luck.
2517